4//SEC Filing
Davis Aaron I. 4
Accession 0000895345-24-000369
CIK 0001819133other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 9:01 PM ET
Size
5.9 KB
Accession
0000895345-24-000369
Insider Transaction Report
Form 4
Davis Aaron I.
DirectorChief Executive Officer
Transactions
- Other
Stock Option (Right to Buy)
2024-09-03+65,000→ 65,000 totalExercise: $10.93Exp: 2034-09-03→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]This option, which was granted as compensation for consulting services, shall vest and become exercisable in 2 substantially equal installments, with 32,500 shares vesting as of 12/03/2024 and 32,500 shares vesting as of 03/03/2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Documents
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001465914
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 9:01 PM ET
- Size
- 5.9 KB